ActiGraph Partners With PDH
PDH is joining ActiGraph’s Accelerant™ partnership program, designed to advance the use of DHTs.
ActiGraph has officially partnered with Precision Digital Health (PDH).
PDH is joining ActiGraph’s Accelerant™ partnership program, designed to advance the use of digital health technologies (DHTs) in clinical development by simplifying CROs’ and technology vendors’ access to raw data streams. PDH’s platform aggregates participant data from multiple sources, such as ActiGraph’s wearable DHTs, to provide clinical insights to multi-disciplinary teams. This partnership will enable PDH to more efficiently present real-time participant journeys and meaningful clinical outcomes to end users.
Reference
ActiGraph Partners with PDH to Advance DHTs in Clinical Research. (2023, April 3).
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
